Sigma Healthcare Ltd
F:S5YA

Watchlist Manager
Sigma Healthcare Ltd Logo
Sigma Healthcare Ltd
F:S5YA
Watchlist
Price: 1.64 EUR -0.61% Market Closed
Market Cap: €2.7B

EV/GP

13.8
Current
128%
More Expensive
vs 3-y average of 6

Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.

EV/GP
13.8
=
Enterprise Value
€34.3B
/
Gross Profit
AU$2.4B

Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.

EV/GP
13.8
=
Enterprise Value
€34.3B
/
Gross Profit
AU$2.4B

Valuation Scenarios

Sigma Healthcare Ltd is trading above its 3-year average

If EV/GP returns to its 3-Year Average (6), the stock would be worth €0.72 (56% downside from current price).

Statistics
Positive Scenarios
0/4
Maximum Downside
-80%
Maximum Upside
No Upside Scenarios
Average Downside
68%
Scenario EV/GP Value Implied Price Upside/Downside
Current Multiple 13.8 €1.64
0%
3-Year Average 6 €0.72
-56%
5-Year Average 2.7 €0.32
-80%
Industry Average 3.1 €0.37
-78%
Country Average 5.8 €0.7
-58%

Forward EV/GP
Today’s price vs future gross profit

Not enough data available to calculate forward EV/GP

Peer Comparison

All Multiples
EV/GP
P/E
All Countries
Close

Market Distribution

Lower than 91% of companies in Australia
Percentile
9th
Based on 1 296 companies
9th percentile
1.5
Low
0 — 3.4
Typical Range
3.4 — 11.1
High
11.1 —
Distribution Statistics
Australia
Min 0
30th Percentile 3.4
Median 5.8
70th Percentile 11.1
Max 27 768.2

Sigma Healthcare Ltd
Glance View

Market Cap
2.7B EUR
Industry
Health Care

In the competitive landscape of Australia’s healthcare sector, Sigma Healthcare Ltd emerges as a vital cog in the country’s pharmacy and healthcare distribution wheel. Born from a humble beginning, the company has strategically evolved into one of the leading pharmaceutical wholesalers, boasting an extensive distribution network that spans across Australia's vast geography. Sigma supplies both prescription medicines and over-the-counter products to numerous independent and branded pharmacies, including recognizable names such as Amcal and Guardian. This distribution forte encapsulates Sigma’s primary revenue stream, as the company capitalizes on the efficiency of its supply chain operations, ensuring pharmaceuticals are delivered seamlessly from manufacturers directly to the doorsteps of pharmacies and hospitals. Beyond distribution, Sigma has diversified its operations to tap into retail pharmacy franchising, leveraging well-established brands to capture consumer loyalty. Operating under its banner of pharmacy brands, Sigma extends support in the form of marketing, retail advisory, and operational assistance to its franchise network, which in turn, feeds into its profitability margins. The company's strategic foresight into expanding its retail and service offerings further underpins its financial architecture, as it looks to balance its ledger not just through wholesale operations but also via the value-added services offered to its network. By orchestrating a symphony of merchandise management, supply chain prowess, and retail consultancy, Sigma Healthcare Ltd not only sustains its market relevance but also weaves itself deeply into the fabric of Australian healthcare delivery.

S5YA Intrinsic Value
1.06 EUR
Overvaluation 35%
Intrinsic Value
Price €1.64
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett